Society guideline links: Psoriasis

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Psoriatic arthritis in adults".)

United States

●National Psoriasis Foundation (NPF): Delphi consensus on vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis (2024)

●NPF: Full guidelines on the perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis (2024)

●American Academy of Dermatology (AAD) and NPF: Joint guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures (2021)

●AAD and NPF: Joint guidelines of care for the management and treatment of psoriasis in pediatric patients (2020)

●AAD and NPF: Joint guidelines of care for the management of psoriasis with systemic non-biological therapies (2020)

●AAD and NPF: Joint guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities (2019)

●AAD and NPF: Joint guidelines of care for the management and treatment of psoriasis with biologics (2019)

●AAD and NPF: Joint guidelines of care for the management and treatment of psoriasis with phototherapy (2019)

Europe

●European Dermatology Forum (EDF): EuroGuiDerm guideline for the systemic treatment of psoriasis vulgaris (2023, partial update 2025)

●European Association for Dermatology and Venereology (EADV): Position statement on statins and psoriasis (2023)

●EDF, EADV, and International Psoriasis Council (IPC): European S3-guideline on the systemic treatment of psoriasis vulgaris, update − Apremilast and secukinumab (2017)

•EDF, EADV, and IPC: European S3-guidelines on the systemic treatment of psoriasis vulgaris, update (2015)

●European Rare and Severe Psoriasis Expert Network (ERASPEN): European consensus statement on phenotypes of pustular psoriasis (2017)

●EADV: Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis (2013)

United Kingdom

●British Association of Dermatologists (BAD): Guidelines for biologic therapy for psoriasis, a rapid update (2020)

●National Institute for Health and Care Excellence (NICE): Clinical guideline on psoriasis – Assessment and management (2012, updated 2017)

●BAD: Guidelines for the safe and effective prescribing of methotrexate for skin disease (2016)

●NICE: Quality standard on psoriasis (2013)

Australia–New Zealand

●Australasian College of Dermatologists (ACD): Consensus adaptation on treatment goals for moderate-to severe psoriasis in paediatric and adult Australian patients (2024)

●Choosing Wisely Australia: Do not recommend that patients take systemic non-sedating antihistamine for itchy rashes, i.e. eczema, psoriasis. Non-sedating antihistamines can be prescribed for urticaria according to the ASCIA guidelines (reviewed 2021)

Japan

●[In English] Japanese Dermatological Association (JDA): Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis (published 2023)

●[In English] JDA: Japanese guidance for use of biologics for psoriasis (the 2022 version) (published 2023)

●[In Japanese] JDA: Guidance for the use of biologics in psoriasis (2022)

●[In Japanese] JDA: Guidance on the use of oral Janus kinase (JAK) inhibitors (JAK1 inhibitors and TYK2 inhibitors) in psoriasis (2022)

●[In English] JDA: Japanese guidelines for the management and treatment of generalized pustular psoriasis – The new pathogenesis and treatment of GPP (2018)

●[In Japanese] JDA: Pustular psoriasis (generalized type) treatment guidelines (2014)